What does Trofinetide (Daybue, Daybue Stix) do in plain English—and how does it work inside your body?
Trofinetide is an FDA-regulated Cytochrome P450 3A4 Inhibitors [MoA] (RxNorm RxCUI 2632857). Mechanistically, 12.1 Mechanism of Action The mechanism by which trofinetide exerts therapeutic effects in patients with Rett syndrome is unknown. As an active cytochrome p450 3a4 inhibitors [moa] moiety (Acadia Pharmaceuticals Inc.), Trofinetide modulates physiological signaling proportional to 8000 mg/1 For Solution exposure and hepatorenal clearance (SPL 2026-09-04). [1][2].
When your doctor writes a prescription for Trofinetide (RxNorm RxCUI 2632857, also dispensed under brand names including Daybue, Daybue Stix), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, 12.1 Mechanism of Action The mechanism by which trofinetide exerts therapeutic effects in patients with Rett syndrome is unknown. As an active cytochrome p450 3a4 inhibitors [moa] moiety (Acadia Pharmaceuticals Inc.), Trofinetide modulates physiological signaling proportional to 8000 mg/1 For Solution exposure and hepatorenal clearance (SPL 2026-09-04). [2].
Across real-world patient logs on dotMD (84% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Trofinetide tablet bottle and confirm with your pharmacist that it matches your prescribed strength (8000 mg/1 For Solution, 5000 mg/1 For Solution, 6000 mg/1 For Solution, 200 mg/mL Solution).